Dual therapy with direct oral anticoagulants significantly increases the risk of stent thrombosis compared to triple therapy

Eur Heart J Cardiovasc Pharmacother. 2020 Apr 1;6(2):128-129. doi: 10.1093/ehjcvp/pvz030.

Authors

Mattia Galli¹, Felicita Andreotti^{1

2}, Domenico D'Amario¹, Rocco Vergallo¹, Rocco A Montone¹, Italo Porto^{3

4}, Filippo Crea^{1

2}

Affiliations

¹ Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, Italy.
² Università Cattolica del Sacro Cuore, Largo Agostino Gemelli 8, 00168 Rome, Italy.
³ Interventional Cardiology Unit, IRCCS Ospedale Policlinico San Martino-Italian IRCCS Cardiovascular Network, University of Genova, Largo R. Benzi 15, 16132 Genova, Italy.
⁴ Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Università di Genova, Largo R. Benzi 15, 16132 Genova, Italy.

PMID: 31309231
DOI: 10.1093/ehjcvp/pvz030

No abstract available

Publication types

Letter
Meta-Analysis

MeSH terms

Atrial Fibrillation / diagnosis
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / epidemiology
Coronary Artery Disease / diagnosis
Coronary Artery Disease / epidemiology
Coronary Artery Disease / therapy*
Coronary Thrombosis / diagnosis
Coronary Thrombosis / epidemiology*
Dual Anti-Platelet Therapy
Factor Xa Inhibitors / administration & dosage*
Factor Xa Inhibitors / adverse effects
Fibrinolytic Agents / administration & dosage*
Fibrinolytic Agents / adverse effects
Humans
Percutaneous Coronary Intervention / adverse effects
Percutaneous Coronary Intervention / instrumentation*
Platelet Aggregation Inhibitors / administration & dosage*
Platelet Aggregation Inhibitors / adverse effects
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Stents*
Time Factors
Treatment Outcome

Substances

Factor Xa Inhibitors
Fibrinolytic Agents
Platelet Aggregation Inhibitors